Pharmacy Is Right For Me
MAY 22, 2023
Jamila Jorden, a pharmacist and academic advisor, recently gave an interview discussing the multifaceted role of pharmacists. She also discussed the importance of experiential education in preparing pharmacy students for their careers. Jamila’s experiences in the pharmacy profession provide valuable insight into the varied roles and responsibilities of pharmacists.
STAT
MAY 22, 2023
WASHINGTON — U.S. health regulators on Monday approved a new, easy-to-use version of a medication to reverse overdoses caused by fentanyl and other opioids driving the nation’s drug crisis. Opvee is similar to naloxone , the lifesaving drug that has been used for decades to quickly counter overdoses of heroin, fentanyl, and prescription painkillers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
MAY 22, 2023
The company's CEO on the vital role its late-stage candidate could play in the lives of DMD patients.
STAT
MAY 22, 2023
In 2012, the United States Preventive Services Task Force convened to determine whether it should recommend kidney disease screening for all Americans. Advocates had been pushing for it, citing ballooning rates of chronic kidney disease. But at the time, the group found there wasn’t enough evidence to say if screening was a net good. That paradigm has since shifted, says Marika Cusick, a Ph.D. candidate in health policy at Stanford.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
MAY 22, 2023
How these consumer and service companies are tapping into major trends in the biopharma industry.
STAT
MAY 22, 2023
I once saw a patient who came to the emergency room with injuries that were clearly related to domestic violence. Instead of offering a compassionate ear and a blanket to cover her exposed body after an assault, her intake nurse rushed through a checklist intended to screen her for social needs. While facing the computer screen, the nurse asked the patient a series of sensitive questions, including one about whether she had experienced domestic violence.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
MAY 22, 2023
The area of North Bellport on Long Island sits in the shadows of a massive landfill. This predominantly Black and Latino neighborhood also has the lowest life expectancy on Long Island, as well as the second-highest rates of asthma. Environmental activists do not think this is a coincidence, and for decades they have waged a battle to shut down the Brookhaven Landfill, which they believe is making their community sick.
BioPharma Dive
MAY 22, 2023
The pharma will pay nearly $90 million to acquire Avrobio’s treatment for cystinosis, an inherited condition caused by the toxic buildup of an amino acid.
STAT
MAY 22, 2023
An oral version of semaglutide, the drug marketed as Ozempic and Wegovy , led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine. In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said
PharmExec
MAY 22, 2023
The market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MAY 22, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because the familiar routine of online meetings, phone calls, and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So to cope, yes, we are brewing cups of stimulation. Our choice so far today is chocolate cappuccino and, as always, we welcome you to join us.
Pharmaceutical Technology
MAY 22, 2023
The Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has accepted an investigational new drug application (IND) for SinoMab BioScience’s SM17 to treat asthma. SM17 is a humanised IgG4-k monoclonal antibody that targets IL-17RB to treat asthma, idiopathic pulmonary fibrosis (IPF), atopic dermatitis (AD) and other immunological disorders.
Drug Patent Watch
MAY 22, 2023
Introducing DrugChatter.com: Empowering Access to Biopharmaceutical Drug Insights through AI Chat We are pleased to introduce DrugChatter.com, a groundbreaking platform that redefines the way professionals obtain concise, cited information on… The post DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights appeared first on DrugPatentWatch - Make Better Decisions.
Express Pharma
MAY 22, 2023
Takeda Biopharmaceuticals India announced a three-year partnership with Save the Children – Bal Raksha Bharat to strengthen the nutritional well-being of expecting and new mothers as well as children in selected areas of Delhi. A company statement informed, “Executing through 200 Anganwadi centres, the intervention will strengthen partnership with the government and provide technical assistance in the form of training, capacity-building, and resource support to frontline workers and servic
BioPharma Dive
MAY 22, 2023
The acquisition would give Ironwood a drug in late-stage testing for a condition known as short bowel syndrome, further building out the company’s gastrointestinal-focused research.
Pharma Times
MAY 22, 2023
ACD856 is the leading candidate therapy on the company’s NeuroRestore platform
BioPharma Dive
MAY 22, 2023
When pharma manufacturers are racing to bring a new product to market, catastrophic printing errors and mislabeled materials can have a significant impact on timelines and budgets.
Pharma Times
MAY 22, 2023
Treatment involves early Alzheimer’s disease and will be potentially used across Great Britain
Integra X Files
MAY 22, 2023
Whether you call it prior review, precertification, or prior authorization (PA), the practice is widespread and under attack. Almost every healthcare professional with experience with PA complains about the time required to respond to the request and the delay involved in getting treatment for a patient. Prior authorization has been popular with the insurance industry because it works.
Express Pharma
MAY 22, 2023
Rakuten Medical, a company developing and commercialising precision, cell-targeting therapies based on its proprietary Alluminox platform, announced that the company has been granted permission from the Indian Central Drugs Standard Control Organization (CDSCO) to conduct its global, pivotal Phase 3 clinical trial (ASP-1929-301/ClinicalTrials.gov Identifier: NCT03769506) evaluating Alluminox treatment (photoimmunotherapy) using ASP-1929 in patients with locoregional, recurrent head and neck squa
The Pharmacist
MAY 22, 2023
GPs in England want to be able to offer private services to their registered NHS patients in certain circumstances and ‘at their discretion’. Voting at the UK LMC conference in London, local medical council (LMC) leaders passed a motion stating that GPs should be allowed to offer paid-for services if they ‘are not routinely offered by […] The post GPs want to provide private services for own patients appeared first on The Pharmacist.
European Pharmaceutical Review
MAY 22, 2023
A review by Swedish researchers has identified the benefits of smart contracts on blockchain platforms in the pharmaceutical supply chain and its role in combating counterfeit drugs. While the counterfeit market is estimated to be a market of over $200 billion and despite its benefits, blockchain technology has not been fully implemented in the pharmaceutical supply chain, according to the paper.
The Pharmacist
MAY 22, 2023
Labour leader Sir Kier Starmer pledged to prioritise prevention, local healthcare and patient choice in his speech at the Progressive Britain Conference today. He outlined goals of accessibility and tackling health inequalities, as well as focusing on major disease areas such as cardiovascular disease, although the speech contained few details about how the plan would […] The post Prevention, access and giving patients control: Labour’s priorities for healthcare appeared first on The Pharm
Express Pharma
MAY 22, 2023
Cadila Pharmaceuticals’ three-dose rabies vaccine, Thrabis, has received the ‘Innovative Product of the Year Award’ at The Golden Globe Tigers Awards. Pankaj Sharma, Vertical Head of Cadila Pharmaceuticals’ Magfam Division, accepted the award virtually on behalf of the company. “ It is an honour to receive this prestigious Innovative Product of the Year award.
Pharmaceutical Technology
MAY 22, 2023
The European Medicines Agency (EMA) has accepted and verified Sobi’s marketing authorisation application for a new factor VIII (FVIII), efanesoctocog alfa, to treat haemophilia A patients of all ages. The application is supported by results from the Phase III XTEND-1 trial in adults and adolescents and backed by the XTEND-Kids paediatric trial in patients aged under 12 years.
Express Pharma
MAY 22, 2023
Arihant Innochem recently organised a seminar in collaboration with its channel partner Lubrizol Life Sciences in Bengaluru. The objective of the seminar was to increase the focus of pharma professionals on applications of its key polymer, carbopol. Carbopol is a versatile polymer having applications as a viscosity modifying agent, drug release retardant, and mucoadhesive agent in oral as well as topical drug delivery.
European Pharmaceutical Review
MAY 22, 2023
Sixty eight percent of people in the UK would consider taking part in a clinical trial, a survey has found. With over 9 in 10 of people living in the UK having never taken part in a clinical trial , there is huge untapped potential for trial recruitment, suggested the survey. The data released by Lindus Health offers pharmaceutical policymakers an understanding of how to help get the UK back on track to fulfil its ambitions to be a life sciences superpower.
The Pharmacist
MAY 22, 2023
Spironolactone is an effective treatment for acne in women that can also be used safely in the longer term, a large UK study has shown. The randomised controlled trial of 410 women over the age of 18 years with mild, moderate and severe acne found a significant difference in both in quality of life and […] The post Spironolactone an effective treatment for acne in women appeared first on The Pharmacist.
Express Pharma
MAY 22, 2023
Eisai Co and Biogen announced that Eisai has submitted a Marketing Authorization Application (MAA) for lecanemab, an investigational anti-amyloid beta (Aβ) protofibril antibody, for the treatment of early Alzheimer’s disease (mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD dementia) with confirmed amyloid pathology in the brain, to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain.
PhRMA
MAY 22, 2023
As we’ve discussed on this blog before, the U.S. Food and Drug Administration’s (FDA) accelerated approval program has served as a critical lifeline for patients with serious and life-threatening conditions. The program was originally established at the urging of patient advocates during the height of the HIV/AIDS epidemic, in which patients waited years for the FDA to review and approve new treatments.
Big Molecule Watch
MAY 22, 2023
Last week, Amneal announced the launch of FYLNETRA (pegfilgrastim-pbbk), a biosimilar to Amgen’s NEULASTA, in the United States. According to the press release, FYLNETRA—Amneal’s third biosimilar launch in the United States since late last year—is used to treat neutropenia (low neutrophils, a type of white blood cell that fights infection) which is commonly experienced by patients undergoing chemotherapy.
World Pharma News
MAY 22, 2023
Insilico Medicine (Insilico), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that the company has nominated a potentially best-in-class preclinical candidate targeting ENPP1 for cancer immunotherapy and the potential treatment of Hypophosphatasia (HPP). ENPP1 is an ecto-nucleotide pyrophosphatase that plays an important role in purinergic signaling that regulates immune, cardiovascular, neurological, and hematological system functions.
Pharmaceutical Technology
MAY 22, 2023
Intercept Pharmaceuticals faced a setback after a US Food and Drug Administration’s (FDA) Advisory Committee (AdCom) meeting on the prospective use of its drug Ocaliva in pre-cirrhotic fibrosis due to nonalcoholic steatohepatitis (NASH) did not go in its favour. Twelve of the 16 AdCom members gave out a negative vote on whether the benefits of 25mg of Ocaliva outweigh the risks in NASH patients with Stage 2 or Stage 3 fibrosis based on available data.
Pharmaceutical Business Review
MAY 22, 2023
The committee voted in support of approval for the vaccine candidate to help prevent the virus in infants through maternal immunisation. According to the committee, the available findings support the efficacy and safety of the vaccine candidate. The VRBPAC’s recommendation, which is not binding, is based on the scientific evidence provided by Pfizer, including primary evaluation data from the Phase III MATernal Immunization Study for Safety and Efficacy (MATISSE) trial announced in November last
Pharmaceutical Technology
MAY 22, 2023
Thermo Fisher Scientific has expanded its sterile manufacturing and research capabilities in the Asia-Pacific region with the opening of a new sterile drug facility in Singapore. The new good manufacturing practices facility was established with support from the Singapore Economic Development Board. It comes with quick vaccine fill-finish capabilities and offers end-to-end pharmaceutical development and manufacturing services.
Expert insights. Personalized for you.
246 
Let's personalize your content